Patents Assigned to Nanocopoeia, Inc.
-
Patent number: 10252289Abstract: A nanoparticle coated hydrogel may be formed by a method of electrospraying nanoparticles on to a surface includes providing a drug and polymer combination in solvent to an inner capillary of a coaxial dual capillary spray nozzle. A coating with a drug that releases over time may be provided. Open and closed matrixes may be selectively formed to help modify time release periods.Type: GrantFiled: August 14, 2015Date of Patent: April 9, 2019Assignee: NANOCOPOEIA, INC.Inventors: Robert A. Hoerr, John V. Carlson
-
Patent number: 9642694Abstract: Devices to deliver one or more active ingredients for medical treatment may include a body of material presenting a surface including a polymer adapted to be rendered conductive such that one or more layers of electrospray particles are formable thereon or a body of conductive material presenting a surface upon which one or more layers of electrospray particles are formable thereon. A coating formed of electrospray particles may be deposited to adhere on the surface of the body of material (e.g., the coating may include one or more layers of coating material, at least one layer of the one or more layers of coating material may include an open matrix coating, the open matrix coating may include one or more active ingredients, the open matrix coating may include one or more polymers and one or more active ingredients, etc.).Type: GrantFiled: December 22, 2014Date of Patent: May 9, 2017Assignees: REGENTS OF THE UNIVERSITY OF MINNESOTA, NANOCOPOEIA, INC.Inventors: Robert A. Hoerr, Da-Ren Chen, John V. Carlson, David Y. H. Pui
-
Patent number: 9108217Abstract: A nanoparticle coated hydrogel may be formed by a method of electrospraying nanoparticles on to a surface includes providing a drug and polymer combination in solvent to an inner capillary of a coaxial dual capillary spray nozzle. A coating with a drug that releases over time may be provided. Open and closed matrixes may be selectively formed to help modify time release periods.Type: GrantFiled: January 31, 2008Date of Patent: August 18, 2015Assignee: Nanocopoeia, Inc.Inventors: Robert A. Hoerr, John V. Carlson
-
Publication number: 20150158051Abstract: A nanoparticle coated hydrogel may be formed by a method of electrospraying nanoparticles on to a surface includes providing a drug and polymer combination in solvent to an inner capillary of a coaxial dual capillary spray nozzle. A coating with a drug that releases over time may be provided. Open and closed matrixes may be selectively formed to help modify time release periods.Type: ApplicationFiled: January 31, 2008Publication date: June 11, 2015Applicant: Nanocopoeia, Inc.Inventors: Robert A. Hoerr, John V. Carlson
-
Patent number: 9040816Abstract: Methods of forming a photovoltaic structures including nanoparticles are disclosed. The method includes electrospray deposition of nanoparticles. The nanoparticles can include TiO2 nanoparticles and quantum dots. In an example, the nanoparticles are formed on a flexible substrate. In various examples, the flexible substrate is light transparent. Photovoltaic structures and apparatus for forming photovoltaic structures are disclosed.Type: GrantFiled: December 10, 2007Date of Patent: May 26, 2015Assignee: Nanocopoeia, Inc.Inventor: Anand Gupta
-
Patent number: 8992471Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.Type: GrantFiled: November 5, 2008Date of Patent: March 31, 2015Assignees: Nanocopoeia, Inc., Louisiana State University Health Sciences Center Office of ResearchInventors: Tammy R. Dugas, Alok Khandelwal, James John Kleinedler, III, John Devlin Foley
-
Patent number: 8992603Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.Type: GrantFiled: October 2, 2012Date of Patent: March 31, 2015Assignees: Nanocopoeia, Inc., Louisiana State University Health Sciences Center Office of ResearchInventors: Tammy R. Dugas, Alok Khandelwal, James John Kleinedler, John Devlin Foley
-
Publication number: 20130323403Abstract: Electrospray methods and systems for coating of objects (e.g., medical devices such as a stent structure) with selected types of coatings (e.g., open matrix coating and closed film coating).Type: ApplicationFiled: May 24, 2013Publication date: December 5, 2013Applicants: REGENTS OF THE UNIVERSITY OF MINNESOTA, NANOCOPOEIA, INC.Inventors: ROBERT A. HOERR, DA-REN CHEN, JOHN V. CARLSON, DAVID Y.H. PUI
-
Publication number: 20130030518Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.Type: ApplicationFiled: October 2, 2012Publication date: January 31, 2013Applicants: LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER OFFICE OF RESEARCH, NANOCOPOEIA, INC.Inventors: Tammy R. DUGAS, Alok KHANDELWAL, James John KLEINEDLER, III, John Devlin FOLEY
-
Publication number: 20110229627Abstract: Electrospray methods and systems for coating of objects (e.g., medical devices such as a stent structure) with selected types of coatings (e.g.Type: ApplicationFiled: May 27, 2011Publication date: September 22, 2011Applicants: NANOCOPOEIA, INC., Regents of the University of MinnesotaInventors: ROBERT A. HOERR, JOHN V. CARLSON, DA-REN CHEN, DAVID Y.H. PUI
-
Publication number: 20100331965Abstract: The present invention relates generally to the maintenance of blow flood using drug eluting stents and/or other coated medical devices to increased length of time of blood flow. Further, the present invention relates to drug-releasing coated devices for reducing smooth muscle cell proliferation and platelet activity to further limit restenosis utilizing resveratrol and quercetin, polyphenols that are linked to the cardioprotection of red wine consumption. The present invention also provides products and methods for treating or preventing atherosclerosis, stenosis, restenosis, smooth muscle cell proliferation, platelet cell activation and other clotting mechanisms, occlusive disease, or other abnormal lumenal cellular proliferation condition in a location within the body of a patient.Type: ApplicationFiled: November 5, 2008Publication date: December 30, 2010Applicant: NANOCOPOEIA, INC.Inventors: Tammy R. Dugas, Alok Khandelwal, James John Kleinedler, III, John Devlin Foley
-
Publication number: 20070278103Abstract: A nanoparticle coated hydrogel may be formed by a method of electrospraying nanoparticles on to a hydrogel surface includes providing a drug and polymer combination in solvent to an inner capillary of a coaxial capillary spray nozzle. A coating with a drug that releases over time may be provided. Open and closed matrixes may be selectively formed to help modify time release periods.Type: ApplicationFiled: January 31, 2007Publication date: December 6, 2007Applicant: Nanocopoeia, Inc.Inventors: Robert Hoerr, John Carlson